U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 7 of 7 results

Status:
US Approved Rx (2022)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Nalmefene is the first medication approved for alcoholism with the primary goal of reducing alcohol intake in an as needed approach. Nalmefene received a marketing authorization valid throughout the European Union on February 25, 2013 and is under de...
Status:
US Approved Rx (1988)
First approved in 1988

Class (Stereo):
CHEMICAL (UNKNOWN)



Ioversol is an organoiodine compound that used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups. It is indicated in adults for peripheral and coronary arteriography and left ventriculography, for exc...
Status:
US Previously Marketed
First approved in 1962

Class (Stereo):
CHEMICAL (ACHIRAL)



Sulfachlorpyridazine is a broad spectrum antibacterial compound which is effective in the treatment of infections caused by gram-positive and gram-negative organisms that are commonly susceptible to sulfonamide therapy and which has been proven by la...
Status:
US Approved Rx (2022)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Nalmefene is the first medication approved for alcoholism with the primary goal of reducing alcohol intake in an as needed approach. Nalmefene received a marketing authorization valid throughout the European Union on February 25, 2013 and is under de...
Status:
US Approved Rx (2022)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Nalmefene is the first medication approved for alcoholism with the primary goal of reducing alcohol intake in an as needed approach. Nalmefene received a marketing authorization valid throughout the European Union on February 25, 2013 and is under de...
Status:
US Approved Rx (2022)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Nalmefene is the first medication approved for alcoholism with the primary goal of reducing alcohol intake in an as needed approach. Nalmefene received a marketing authorization valid throughout the European Union on February 25, 2013 and is under de...
Status:
US Previously Marketed
First approved in 1962

Class (Stereo):
CHEMICAL (ACHIRAL)



Sulfachlorpyridazine is a broad spectrum antibacterial compound which is effective in the treatment of infections caused by gram-positive and gram-negative organisms that are commonly susceptible to sulfonamide therapy and which has been proven by la...